Internal cue exposure and the treatment of substance use disorders: Lessons from the treatment of panic disorder

Journal of Anxiety Disorders

Volumn 18, Issue 1, 2004, Pages 69-87

  Otto, Michael W ^a   Safren, Steven A ^a   Pollack, Mark H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benzodiazepine discontinuation; Emotional acceptance; Emotional avoidance; Interoceptive exposure; Panic disorder; Substance abuse

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; METHADONE;

AGORAPHOBIA; ANXIETY DISORDER; BEHAVIOR THERAPY; COGNITION; COPING BEHAVIOR; DEPRESSION; DRUG DEPENDENCE TREATMENT; DRUG POTENCY; DRUG WITHDRAWAL; GENDER; HUMAN; LITERATURE; NEUROPHYSIOLOGY; PANIC; PROVOCATION; PSYCHOSOCIAL CARE; RELAPSE; REVIEW; SENSATION; SUBSTANCE ABUSE; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

EID: 0346094232     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2003.07.007     Document Type: Article

References (92)

1. Barlow, D. H., & Craske, M. G. Mastery of your anxiety and panic. Albany: Graywind Publications.
2. Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. A randomized controlled trial of cognitive-behavioral treatment vs. imipramine and their combination for panic disorder: primary outcome results. Journal of the American Medical Association. 283:2000;2529-2536.
3. Beck K.H., Thombs D.L., Mahoney C.A., Finger K.M. Social context and sensation seeking: gender differences in college student drinking motivations. International Journal of Addictions. 30:1995;1101-1105.
4. Bonn J.A., Harrison J., Rees W.L. Lactate-induced anxiety: therapeutic implications. British Journal of Psychiatry. 119:1971;468-470.
5. Breslin C.F., Zack M., McMain S. An information-processing analysis of mindfulness: implications for relapse prevention in the treatment of substance abuse. Clinical Psychology: Science and Practice. 9:2002;275-299.
6. Brown R.A., Kahler C.W., Zvolensky M.J., Lejuez C.W., Ramsey S.E. Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Addictive Behaviors. 26:2001;887-899.
7. Bruce T.J., Spiegel D.A., Gregg S.F., Nuzzarello A. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. American Journal of Psychiatry. 152:1995;1156-1160.
8. Cahill, S. P., Zoellner, L. A., Feeny, N. C., & Riggs D. S. (2003). Sequential treatment for child abuse-related PTSD: methodological comment on Cloitre et al. (2002). Manuscript under review.
9. Cantanzaro S.J., Mearns J. Measuring generalized expectations for negative mood regulation: initial scale development and implications. Journal of Personality Assessment. 54:1990;546-563.
10. Carroll K.M., Rounsaville B.I., Gordon L.T., Nich C., Jatlow P., Bisighini R.M., Gawin F. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Archives of General Psychiatry. 51:1994;177-187.
11. Chaney E.F., Roszell D.K., Cummings C. Relapse in opiate addicts: a behavioral analysis. Addictive Behaviors. 7:1982;877-884.
12. Childress A.R., Ehrman R., McLellan A.T., MacRae J., Natale M., O'Brien C.P. Can induced moods trigger drug-related responses in opiate abuse patients? Journal of Substance Abuse Treatment. 11:1994;17-23.
13. Cloitre M., Koenen K.C., Cohen L.R., Han H. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. Journal of Consulting and Clinical Psychology. 70:2002;1067-1074.
14. Clum G.A., Clum G.A., Surls R. A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology. 61:1993;317-326.
15. Cooper M.L., Russell M., Skinner J.B., Frone M.R., Mudar P. Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. Journal of Abnormal Psychology. 101:1992;139-152.
16. Donnell C.D., McNally R.J. Anxiety sensitivity and history of panic as predictors of response to hyperventilation. Behavioral Research and Therapy. 28:1989;83-85.
17. Drummond D.C., Glautier S.P. A controlled trial of cue exposure treatment in alcohol dependence. Journal of Consulting and Clinical Psychology. 62:1994;809-817.
18. Feldner M.T., Zvolensky M.J., Eifert G.H., Spira A.P. Emotional avoidance: an experimental test of individual differences and response suppression using biological challenge. Behaviour Research and Therapy. 41:2003;403-411.
19. Forsyth J.P., Parker J.D., Finlay C.G. Anxiety sensitivity, controllability and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance abusing veterans. Addictive Behaviors. 28:2003;851-870.
20. Franken I.H.A., De Haan H.A., Van Der Meer C.W., Haffmans P.M.J., Hendriks V.M. Cue reactivity and effects of cue exposure in abstinent posttreatment drug users. Journal of Substance Abuse Treatment. 16:1999;81-85.
21. Fyer A.J., Liebowitz M.R., Gorman J.M., Campeas R., Levin A., Davies S.O., Goetz D., Klein D.F. Discontinuation of alprazolam treatment in panic patients. American Journal of Psychiatry. 144:1987;303-308.
22. Gould R.A., Otto M.W., Pollack M.H. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review. 15:1995;819-844.
23. 2-induced anxiety symptoms. Journal of Nervous and Mental Disease. 171:1983;506-508.
24. Harvey J.M., Richards M.C., Dziadosz T., Swindell A. Misinterpretations of ambiguous stimuli in panic disorder. Cognitive Therapy and Research. 17:1993;235-248.
25. Haslam M.T. The relationship between the effect of lactate infusion on anxiety states and their amelioration by carbon dioxide inhalation. British Journal of Psychiatry. 125:1974;88-90.
26. Hayes, S., Bissett, R., Strosahl, K., Follette, W., Polusny, M., Pistorello, J., Toarmino, D., Batten, S., Dykstra, T., Stewart, S., Zvolensky, M., Eifert, G., Bond, F., & Bergan, J. (2002). Psychometric properties of the Acceptance and Action Questionnaire (AAQ). Manuscript submitted for publication.
27. Hayes, S. C., Jacobson, N. S., Follette, V. M., & Dougher, M. J. (Eds.). (1994). Acceptance and change: content and context in psychotherapy. Reno NV: Context Press.
28. Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and Commitment Therapy. New York: Guilford Press.
29. Hayes S.C., Wilson K.G., Strosahl K., Gifford E.V., Follette V.M. Experiential avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. Journal of Consulting and Clinical Psychology. 64:1996;1152-1168.
30. Heather N., Stallard A., Tebbutt J. Importance of substance cues in relapse among heroin users: comparison of two methods of investigation. Addictive Behaviors. 16:1991;41-49.
31. Hegel M.T., Ravaris C.L., Ahles T.A. Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy. 25:1994;183-195.
32. Jacobson N.S., Martell C.R., Dimidjian S. Behavioral activation treatment for depression: returning to contextual roots. Clinical Psychology: Science and Practice. 8:2001;255-270.
33. Linehan, M. M. (1993). Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press.
34. Linehan M.M., Schmidt H.I., Dimeff L.A., Craft J.C., Kanter J., Comtois K.A. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions. 8:1999;279-292.
35. Litman G.K., Stapleton J., Oppenheim A.N., O'Brien C.P., Childress A.R., McLellan T., Ehrman R. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors. 15. 1990;355-365.
36. Litman G.K., Stapelton J., Oppenheim A.N., Peleg M., Jackson P. Situations related to alcoholism relapse. British Journal of Addictions. 78:1983;381-389.
37. Lowman C., Allen J., Stout R.L. Section II. Marlatt's taxonomy of high-risk situations for relapse: replication and extension. Addiction. 91(Suppl):1996;s51-s171.
38. Marlatt G.A. Buddhist philosophy and the treatment of addictive behavior. Cognitive and Behavioral Practice. 9:2002;44-50.
39. Maude-Griffin P.M., Humfleet G.L., Reilly P.M., Tusel D.J., Hall s.M. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. Journal of Consulting and Clinical Psychology. 66:1998;832-837.
40. McNally, R. J. (1994). Panic disorder: a critical analysis. New York: Guilford Press.
41. Mellman T.A., Uhde T.W. Withdrawal syndrome with gradual tapering of alprazolam. American Journal of Psychiatry. 11:1986;1464-1466.
42. Michelini S., Cassano G.B., Frare F., Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. 29:1996;127-134.
43. Monti, P. M., Rohsenow, D. J., Colby, S. M., Abrams, D. B. (1995). Smoking among alcoholics during and after treatment: implications for models, treatment strategies, and policy. In: J. B. Ferig (Ed.), Alcohol and tobacco: from basic science to policy. National Institute of Alcohol Abuse and Addiction.
44. Monti P.M., Rohsenow D.J., Rubonis A.V., Niaura R.S., Sirota A.D., Colby S.M., Abrams D.B. Alcohol cue reactivity: effects of detoxification and extended exposure. Journal of Studies on Alcohol. 54(2):1993;235-245.
45. Niaura R.S., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. Journal of Abnormal Psychology. 97:1988;133-152.
46. Novak A., Burgess E.S., Clark M., Zvolensky M.J., Brown R.A. Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption. Journal of Anxiety Disorders. 17:2003;165-180.
47. Noyes R., Garvey M.J., Cook B., Suelzer M. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry. 148:1991;517-523.
48. Nunes, E. V., & Quitkin, F. M. (1997). Treatment of depression in drug-dependent patients: effects on mood and drug use. In: L. S. Onken, J. D. Blaine, S. Genser, & A. M. Horton (Eds.), Treatment of drug-dependent individuals with comorbid mental disorders (pp. 61-84). NIDA Research Monograph 172 (NIH Publication No. 97-4172). Washington, DC: U.S. Government Printing Office.
49. O'Brien C.P., Childress A.R., McLellan T., Eherman R. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors. 15:1990;355-365.
50. O'Connell K.A., Martin E.J. Highly tempting situations associated with abstinence temporary, lapse and relapse among participants in smoking cessation programs. Journal of Consulting and Clinical Psychology. 55:1987;367-371.
51. Otto, M. W., Barlow, D. H., Pollack, M. H., Spiegel, D. A. (1999, November 11-14). Further evaluation of panic control therapy for benzodiazepine discontinuation. Paper presented at the 33rd Association for Advancement of Behavior Therapy convention in Toronto, Canada.
52. Otto M.W., Fava M., Penava S.A., Bless E., Muller R.T., Rosenbaum J.F. Life event and cognitive predictors of perceived stress before and after treatment for major depression. Cognitive Therapy and Research. 21:1997;409-420.
53. Otto, M. W., Jones, J. C., Craske, M. G., & Barlow, D. H. (1996). Stopping anxiety medication: panic control therapy for benzodiazepine discontinuation (Therapist Guide). San Antonio, TX: Psychological Corporation.
54. Otto, M. W., Penava, S. A., Bolton, E., & Pollack, M. H. (2002). Therapist Manual for Cognitive-Behavior Therapy for Interoceptive Cues (CBT-IC). Unpublished manuscript. Massachusetts General Hospital, WACC-812, 15 Parkman St., Boston, MA.
55. Otto, M. W., Pollack M. H., Ball, S. G., & Rosenbaum, J. F. (1995). Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. In: L. S. Onken & J. D. Blaine (Eds.), Integrating behavioral therapies with medications in the treatment of drug dependence (pp. 143-166). NIDA Research Monograph 150 (NIH Publication No. 95-3899). Washington, DC: U.S. Government Printing Office.
56. Otto M.W., Pollack M.H., Meltzer-Brody S., Rosenbaum J.F. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients. Psychopharmacology Bulletin. 28:1992;123-130.
57. Otto M.W., Pollack M.H., Sachs G.S., Reiter S.R., Meltzer-Brody S., Rosenbaum J.F. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry. 150:1993;1485-1490.
58. Otto, M. W., & Reilly-Harrington, N. (1999). The impact of treatment on anxiety sensitivity. In: S. Taylor (Ed.), Anxiety sensitivity: theory, research and treatment of the fear of anxiety (pp. 321-336). New Jersey: Lawrence Erlbaum.
59. Pollack M.H., Penava S.A., Bolton E., Worthington J.J., Allen G.L., Farach F.J., Otto M.W. A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment. 23:2002;335-342.
60. Powell J., Gray J., Bradley B.P. Subjective craving for opiates: evaluation of a cue exposure protocol for use with detoxified opiate addicts. British Journal of Clinical Psychology. 32:1993;39-53.
61. Powell J.P., Gray J.A., Bradley B.P., Kasvikis Y., Strang J., Barratt L., Marks I. The effects of exposure to drug-related cues in detoxified opiate addicts: a theoretical review and some new data. Addictive Behaviors. 15:1990;339-354.
62. Raw M., Russell M.A.H. Rapid smoking, cue exposure, and support in the modification of smoking. Behavior Research and Therapy. 18:1980;363-372.
63. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. 264:1990;2511-2518.
64. Robbins C.J. Zen principles and mindfulness practice in Dialectical Behavior Therapy. Cognitive and Behavioral Practice. 9:2002;50-57.
65. Robbins S.J., Ehrman R.N., Childress A.R., Cornish J.W., O'Brien C.P. Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and Alcohol Dependence. 59:2000;33-42.
66. Roemer L., Orsillo S.M. Expanding our conceptualization of and treatment for generalized anxiety disorder: integrating mindfulness/acceptance-based approaches with existing cognitive behavioral models. Clinical Psychology: Science and Practice. 9:2002;54-68.
67. Rohsenow J.H., Monti P.M. Does urge to drink predict relapse after treatment? Alcohol Research and Health. 23:1999;225-232.
68. Roy-Byrne P.P., Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. American Journal of Medicine. 84:1988;1041-1052.
69. Rubonis A.V., Colby S.M., Monti P.M., Rohsenow D.T., Gulliver S.B., Sirota A.D. Alcohol cue reactivity and mood induction in male and female alcoholics. Journal of Studies on Alcohol. 55:1994;487-494.
70. Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Journal of Psychiatric Research. 27:1993;97-110.
71. Schmidt N.B., Lerew D.R., Jackson R.J. The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. Journal of Abnormal Psychology. 106:1997;355-364.
72. 2 challenge. Behavior Therapy. 30:1999;623-640.
73. 2 challenge in patients with panic disorder. Journal of Abnormal Psychology. 106:1997;630-638.
74. Schmidt N.B., Wolaway-Bickel K., Trakowski J., Santiago H., Storey J., Koselka M., Cook J. Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining. Journal of Consulting and Clinical Psychology. 68:2000;417-424.
75. Scourfield J., Stevens D.E., Merikangas K.R. Substance abuse, comorbidity, and sensation seeking: gender differences. Comprehensive Psychiatry. 37:1996;384-392.
76. Shear M.K., Fyer A.J., Ball G., Josephson S., Fitzpatrick M., Gitlin B., Frances A., Gorman J., Liebowitz M., Klein D.F. Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. American Journal of Psychiatry. 148:1991;795-797.
77. Sherman J.E., Zinser M.C., Sideroff S.I., Baker T.B. Subjective dimensions of heroin urges: influence of heroin-related and affectively negative stimuli. Addictive Behaviors. 14:1989;611-623.
78. Smits, J. A. J., Cho, Y. C., Powers, M. B., & Telch, M. J. (2003). Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis. Manuscript under review.
79. Spiegel D.A., Bruce T.J., Gregg S.F., Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder. American Journal of Psychiatry. 151:1994;876-881.
80. Stewart S.H., Westra H.A., Thompson C.E., Conrad B.E. Effects of naturalistic benzodiazepine use on the selective processing of threat cues among anxiety disorder patients. Cognitive Therapy and Research. 24:2000;67-85.
81. Stewart S.H., Zeitlin S.B. Anxiety sensitivity and alcohol use motives. Journal of Anxiety Disorders. 9:1995;229-240.
82. Stewart S.H., Zvolensky M.J., Eifert G.H. The relations of anxiety sensitivity, experiential avoidance, and alexithymic coping to young adults' motivations for drinking. Behavior Modification. 26:2002;274-296.
83. Taylor, S. (1999). Anxiety sensitivity: theory, research and treatment of the fear of anxiety. New Jersey: Lawrence Erlbaum.
84. Toneatto T. A metacognitive theory for anxiety disorders: Buddhist psychology applied. Cognitive and Behavioral Practice. 9:2002;72-78.
85. Tyrer P., Murphy S., Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders. 19:1990;53-61.
86. Wells A. GAD, metacognition, and mindfulness: an information processing analysis. Clinical Psychology: Science and Practice. 9:2002;95-100.
87. Wikler, A. (1965). Conditioning factors in opiate addiction and relapse. In: D. I. Wilner & G. G. Kassenbaum (Eds.), Narcotics (pp. 85-100). New York: McGraw-Hill.
88. Zvolensky M.J., Eifert G.H. A review of psychological factors/processes affecting anxious responding during voluntary hyperventilation and inhalations of carbon dioxide-enriched air. Clinical Psychology Review. 21:2000;375-400.
89. Zvolensky M.J., Eifert G.H., Lejuez C.W. Emotional control during recurrent 20% carbon dioxide-enriched air induction: relation to individual difference variables. Emotion. 2:2001;148-165.
90. Zvolensky M.J., Feldner M.T., Eifert G.H., Brown R.A. Affective style among smokers: understanding anxiety sensitivity, emotional reactivity, and distress tolerance using biological challenge. Addictive Behaviors. 26:2001;901-915.
91. Zweben J.E. Methadone maintenance in the treatment of opioid dependence: a current perspective. The Western Journal of Medicine. 152:1990;588-599.
92. Zywiak W., Connors G.J., Maisto S., Westerberg V.S. Section IIA. Replication and extension of Marlatt's taxonomy: relapse research and the reasons for drinking questionnaire: a factor analysis of Marlatt's relapse taxonomy. Addiction. 91:1996;s121-s130.